Clinical Trial Update: Treatment of Tumors in the Urinary Collecting System of the Kidney or Ureter Using a Light Activated Drug (WST11) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating a light-activated drug (WST11) for treating tumors in the urinary collecting system of the kidney or ureter has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma

Drugs mentioned

• WST11 (WST11)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Upper Tract Urothelial Carcinoma | Phase 1 | Status: COMPLETED